[Hemorrhagic diathesis in viral hepatitis and new therapeutic prospects (tranhexamic acid)].
D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D006474:Hemorrhagic Disorders / Q000188:drug therapy* / Q000209:etiology; D006506:Hepatitis A / Q000150:complications*; D008744:Methylamines / Q000494:pharmacology / Q000627:therapeutic use; D010958:Plasminogen
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D010958:Plasminogen
Diatesi emorragiche nell'epatite virale e nuove prospettive terapeutiche (ac. tranexamico.